228 related articles for article (PubMed ID: 24654603)
1. Therapeutic potential of tyrosine kinase 2 in autoimmunity.
Liang Y; Zhu Y; Xia Y; Peng H; Yang XK; Liu YY; Xu WD; Pan HF; Ye DQ
Expert Opin Ther Targets; 2014 May; 18(5):571-80. PubMed ID: 24654603
[TBL] [Abstract][Full Text] [Related]
2. A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways.
Chen CX; Zhang W; Qu S; Xia F; Zhu Y; Chen B
Cell Commun Signal; 2023 Oct; 21(1):287. PubMed ID: 37845748
[TBL] [Abstract][Full Text] [Related]
3. TYK2: an emerging therapeutic target in rheumatic disease.
Morand E; Merola JF; Tanaka Y; Gladman D; Fleischmann R
Nat Rev Rheumatol; 2024 Apr; 20(4):232-240. PubMed ID: 38467779
[TBL] [Abstract][Full Text] [Related]
4. Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune Diseases.
Mammoliti O; Martina S; Claes P; Coti G; Blanque R; Jagerschmidt C; Shoji K; Borgonovi M; De Vos S; Marsais F; Oste L; Quinton E; López-Ramos M; Amantini D; Brys R; Jimenez JM; Galien R; van der Plas S
J Med Chem; 2024 Jun; 67(11):8545-8568. PubMed ID: 38805213
[TBL] [Abstract][Full Text] [Related]
5. Discovery of WD-890: A novel allosteric TYK2 inhibitor for the treatment of multiple autoimmune diseases.
Fang Z; Sun H; Wang Y; Sun Z; Yin M
Biomed Pharmacother; 2023 Nov; 167():115611. PubMed ID: 37778274
[TBL] [Abstract][Full Text] [Related]
6. Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise.
Danese S; Peyrin-Biroulet L
Inflamm Bowel Dis; 2021 Nov; 27(12):2023-2030. PubMed ID: 34089259
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279.
Leit S; Greenwood J; Carriero S; Mondal S; Abel R; Ashwell M; Blanchette H; Boyles NA; Cartwright M; Collis A; Feng S; Ghanakota P; Harriman GC; Hosagrahara V; Kaila N; Kapeller R; Rafi SB; Romero DL; Tarantino PM; Timaniya J; Toms AV; Wester RT; Westlin W; Srivastava B; Miao W; Tummino P; McElwee JJ; Edmondson SD; Masse CE
J Med Chem; 2023 Aug; 66(15):10473-10496. PubMed ID: 37427891
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 3-(4-(2-((1
Zhang C; Qi W; Li Y; Tang M; Yang T; Liu K; Chen Y; Deng D; Xiang M; Chen L
J Med Chem; 2021 Feb; 64(4):1966-1988. PubMed ID: 33593051
[TBL] [Abstract][Full Text] [Related]
9. Selective Janus kinase inhibition preserves interferon-λ-mediated antiviral responses.
Schnepf D; Crotta S; Thamamongood T; Stanifer M; Polcik L; Ohnemus A; Vier J; Jakob C; Llorian M; Gad HH; Hartmann R; Strobl B; Kirschnek S; Boulant S; Schwemmle M; Wack A; Staeheli P
Sci Immunol; 2021 May; 6(59):. PubMed ID: 33990378
[TBL] [Abstract][Full Text] [Related]
10. Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors.
Jensen LT; Attfield KE; Feldmann M; Fugger L
EBioMedicine; 2023 Nov; 97():104840. PubMed ID: 37863021
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Tyrosine Kinase 2 (TYK2) Pseudokinase Domain: Discovery of the Selective TYK2 Inhibitor ABBV-712.
Breinlinger E; Van Epps S; Friedman M; Argiriadi M; Chien E; Chhor G; Cowart M; Dunstan T; Graff C; Hardee D; Herold JM; Little A; McCarthy R; Parmentier J; Perham M; Qiu W; Schrimpf M; Vargo T; Webster MP; Wu F; Bennett D; Edmunds J
J Med Chem; 2023 Oct; 66(20):14335-14356. PubMed ID: 37823891
[TBL] [Abstract][Full Text] [Related]
12. Anti-leukaemic activity of the TYK2 selective inhibitor NDI-031301 in T-cell acute lymphoblastic leukaemia.
Akahane K; Li Z; Etchin J; Berezovskaya A; Gjini E; Masse CE; Miao W; Rocnik J; Kapeller R; Greenwood JR; Tiv H; Sanda T; Weinstock DM; Look AT
Br J Haematol; 2017 Apr; 177(2):271-282. PubMed ID: 28295194
[TBL] [Abstract][Full Text] [Related]
13. Recent progress on tyrosine kinase 2 JH2 inhibitors.
Deng L; Wan L; Liao T; Wang L; Wang J; Wu X; Shi J
Int Immunopharmacol; 2023 Aug; 121():110434. PubMed ID: 37315371
[TBL] [Abstract][Full Text] [Related]
14. FLT3 inhibitors for the treatment of autoimmune disease.
Whartenby KA; Small D; Calabresi PA
Expert Opin Investig Drugs; 2008 Nov; 17(11):1685-92. PubMed ID: 18922105
[TBL] [Abstract][Full Text] [Related]
15. From Science to Success? Targeting Tyrosine Kinase 2 in Spondyloarthritis and Related Chronic Inflammatory Diseases.
Hromadová D; Elewaut D; Inman RD; Strobl B; Gracey E
Front Genet; 2021; 12():685280. PubMed ID: 34290741
[TBL] [Abstract][Full Text] [Related]
16. Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk.
Yarmolinsky J; Amos CI; Hung RJ; Moreno V; Burrows K; Smith-Byrne K; Atkins JR; Brennan P; ; McKay JD; Martin RM; Davey Smith G
Int J Cancer; 2022 Dec; 151(12):2155-2160. PubMed ID: 35747941
[TBL] [Abstract][Full Text] [Related]
17. Innovative Therapeutic Strategies in TYK2-Targeted Treatments: From Cancer to Autoimmune Disorders.
Kargbo RB
ACS Med Chem Lett; 2024 Feb; 15(2):174-176. PubMed ID: 38352839
[TBL] [Abstract][Full Text] [Related]
18. Identification of imidazo[1,2-
Moslin R; Gardner D; Santella J; Zhang Y; Duncia JV; Liu C; Lin J; Tokarski JS; Strnad J; Pedicord D; Chen J; Blat Y; Zupa-Fernandez A; Cheng L; Sun H; Chaudhry C; Huang C; D'Arienzo C; Sack JS; Muckelbauer JK; Chang C; Tredup J; Xie D; Aranibar N; Burke JR; Carter PH; Weinstein DS
Medchemcomm; 2017 Apr; 8(4):700-712. PubMed ID: 30108788
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship study of central pyridine-derived TYK2 JH2 inhibitors: Optimization of the PK profile through C4' and C6 variations.
Xiao Z; Yang MG; Liu C; Sherwood T; Gilmore JL; Lin J; Li P; Wu DR; Tokarski J; Li S; Cheng L; Xie C; Fan J; Dierks E; Strnad J; Cvijic ME; Khan J; Ruzanov M; Galella M; Khandelwal P; Dyckman AJ; Mathur A; Lombardo LJ; Macor JE; Carter PH; Aranibar N; Burke JR; Weinstein DS
Bioorg Med Chem Lett; 2023 Jul; 91():129373. PubMed ID: 37315697
[TBL] [Abstract][Full Text] [Related]
20. TYK2 Inhibitors for Treating Autoimmune and Inflammatory Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Mar; 15(3):320-321. PubMed ID: 38505839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
